Reversible Pancallosal Signal Changes in Febrile Encephalopathy: Report of 2 Cases

References

1. 1.↵
   1. McLeod NA,
   2. William JP,
   3. Machen B,
   4. et al

   . Normal and abnormal morphology of corpus callosum. Neurology 1987; 37: 1240–42

   Abstract/FREE Full Text
2. 2.↵
   1. Uchino Y,
   2. Takase K,
   3. Nomiyama R,
   4. et al

   . Acquired lesions of the corpus callosum: MR imaging. Eur Radiol 2006; 16: 905–14

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Takanashi J,
   2. Barkovich AJ,
   3. Shiihara T,
   4. et al

   . Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol 2006; 27: 836–38

   Abstract/FREE Full Text
4. 4.↵
   1. Okumura A,
   2. Kidokoro H,
   3. Tsuji T,
   4. et al

   . Differences of clinical manifestations according to the patterns of brain lesions in acute encephalopathy with reduced diffusion in the bilateral hemispheres. AJNR Am J Neuroradiol 2009; 30: 825–30

   Abstract/FREE Full Text
5. 5.↵
   1. Maeda M,
   2. Tsukahara H,
   3. Terada S,
   4. et al

   . Reversible splenial lesions with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol 2006; 33: 229–36

   PubMedWeb of Science
6. 6.↵
   1. Takanashi J,
   2. Barkovich AJ,
   3. Yamaguchi K,
   4. et al

   . Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. AJNR Am J Neuroradiol 2004; 25: 798–802

   Abstract/FREE Full Text
7. 7.↵
   1. Bulakbasi N,
   2. Kocaoglu M,
   3. Tayfun C,
   4. et al

   . Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 2006; 27: 1983–86

   Abstract/FREE Full Text
8. 8.↵
   1. Tada H,
   2. Takanashi J,
   3. Barkovich AJ

   . Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 2004; 63: 1854–58

   Abstract/FREE Full Text
9. 9.↵
   1. Takanashi J

   . Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev 2009; 31: 521–28

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Kobuchi N,
    2. Tsukahara H,
    3. Kawamura Y,
    4. et al

    . Reversible diffusion-weighted MR findings of Salmonella enteritidis-associated encephalopathy. Eur Neurol 2003; 49: 182–84

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Doherty MJ,
    2. Jayadev S,
    3. Watson NF,
    4. et al

    . Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 2005; 62: 433–37

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Kalita J,
    2. Misra UK

    . EEG in dengue virus infection with neurological manifestations: a clinical and CT/MRI correlation. Clinical Neurophysiol 2006; 117: 2252–56. Epub 2006 Aug 22

    CrossRef
13. 13.↵
    1. Wasay M,
    2. Channa R,
    3. Jumani M,
    4. et al

    . Encephalitis and myelitis associated with dengue viral infection: clinical and neuroimaging features. Clin Neurol Neurosurg 2008; 110: 635–40. Epub 2008 May 7

    CrossRefPubMedWeb of Science